This study investigates advanced pancreatic cancer. It looks at how the investigational medication works in people with this condition.
The study evaluates the safety and effects of the investigational medication on patients. It checks how the body processes the medication and observes any changes in the condition.
- Who can participate: Adults 18 years or older with pancreatic adenocarcinoma can participate. Eligible participants have tried other treatments or decided against standard treatments and must meet certain health criteria.
- Study details: Participants will take the investigational medication orally twice a day. They will be monitored for safety and can stop the treatment anytime. A placebo is not used in this study.